Chandelier
Senior Member (Voting Rights)
COVID-19-associated neurological and psychological manifestations
Long COVID is estimated to affect between 80 and 400 million people globally, with an incidence of 5–20% in the community and up to 50% among hospitalized patients following acute SARS-CoV-2 infection.
Common neuropsychiatric and mental health symptoms of long COVID include memory deficits, executive dysfunction, anxiety, depression, recurring headaches, sleep disturbances, neuropathies, problems with taste and smell, and dizziness that accompanies erratic heart rates and severe post-exertional malaise.
Underlying pathophysiological mechanisms includes SARS-CoV-2 viral persistence, herpesvirus reactivation, microbiota dysbiosis, autoimmunity, clotting and endothelial abnormalities, and chronic immune activation.
Owing to the variability in the clinical presentation, management must be tailored based on a patient’s presenting symptoms.
Web | DOI | PDF | Nature Reviews Disease Primers
Paywall
Wilson, Jo Ellen; Gurdasani, Deepti; Helbok, Raimund; Ozturk, Serefnur; Fraser, Douglas D.; Filipović, Saša R.; Peluso, Michael J.; Iwasaki, Akiko; Yasuda, Clarissa Lin; Bocci, Tommaso; Priori, Alberto; Altmann, Daniel; Alwan, Nisreen A.; Wesley Ely, E.
Abstract
Long COVID is an infection-associated chronic condition that typically occurs within 3 months of acute COVID-19 infection in which symptoms are intermittently or continuously present for at least 3 months.Long COVID is estimated to affect between 80 and 400 million people globally, with an incidence of 5–20% in the community and up to 50% among hospitalized patients following acute SARS-CoV-2 infection.
Common neuropsychiatric and mental health symptoms of long COVID include memory deficits, executive dysfunction, anxiety, depression, recurring headaches, sleep disturbances, neuropathies, problems with taste and smell, and dizziness that accompanies erratic heart rates and severe post-exertional malaise.
Underlying pathophysiological mechanisms includes SARS-CoV-2 viral persistence, herpesvirus reactivation, microbiota dysbiosis, autoimmunity, clotting and endothelial abnormalities, and chronic immune activation.
Owing to the variability in the clinical presentation, management must be tailored based on a patient’s presenting symptoms.
Web | DOI | PDF | Nature Reviews Disease Primers
Paywall